Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium
about
Highly specific PET imaging of prostate tumors in mice with an iodine-124-labeled antibody fragment that targets phosphatidylserineBiomarkers and molecular probes for cell death imaging and targeted therapeuticsMembrane Mediated Antimicrobial and Antitumor Activity of Cathelicidin 6: Structural Insights from Molecular Dynamics Simulation on Multi-Microsecond ScaleAnticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targetingLigand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic ResponseExposure of phosphatidylserine on the cell surfaceEndothelial cell heterogeneityHigh resolution tumor targeting in living mice by means of multispectral optoacoustic tomographyPhosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions.Estrogen promotes Leydig cell engulfment by macrophages in male infertilityMonitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With 99mTc-Labeled Duramycin SPECT/CT.Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model.Transbilayer phospholipids molecular imaging.The interconnectedness of cancer cell signaling.PE and PS Lipids Synergistically Enhance Membrane Poration by a Peptide with Anticancer PropertiesToward an animal model of the human tear film: biochemical comparison of the mouse, canine, rabbit, and human meibomian lipidomes.Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses.Phosphatidylserine synthase 2: high efficiency for synthesizing phosphatidylserine containing docosahexaenoic acid.An authentic imaging probe to track cell fate from beginning to end.Identification of lipid-phosphatidylserine (PS) as the target of unbiasedly selected cancer specific peptide-peptoid hybrid PPS1.Cancer subclonal genetic architecture as a key to personalized medicine.Targeting Membrane Lipid a Potential Cancer Cure?Measuring response to therapy by near-infrared imaging of tumors using a phosphatidylserine-targeting antibody fragment.Forms, crosstalks, and the role of phospholipid biosynthesis in autophagy.Tumor endothelial markers as a target in cancer.Bioassays in natural product research - strategies and methods in the search for anti-inflammatory and antimicrobial activity.The phospholipid code: a key component of dying cell recognition, tumor progression and host-microbe interactionsPhosphatidylethanolamine targeting for cell death imaging in early treatment response evaluation and disease diagnosis.A high-affinity near-infrared fluorescent probe to target bombesin receptors.Liposomal encapsulation enhances in vivo near infrared imaging of exposed phosphatidylserine in a mouse glioma model.Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationThe anticancer natural product ophiobolin A induces cytotoxicity by covalent modification of phosphatidylethanolamine.L-methionase: a therapeutic enzyme to treat malignancies.The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells.Lipid-packing perturbation of model membranes by pH-responsive antimicrobial peptides.Identification of CD300a as a new hypoxia-inducible gene and a regulator of CCL20 and VEGF production by human monocytes and macrophages.Extracellular vesicle budding is inhibited by redundant regulators of TAT-5 flippase localization and phospholipid asymmetry.Venom-based peptide therapy: insights into anti-cancer mechanism.
P2860
Q21132365-97ED520D-EB6D-42F4-9F85-9BBCC66B19BBQ26866387-E8F6EA79-5223-4E01-8444-931054C94962Q27335132-BA7675A5-8ECA-43A2-82D3-5C1240192C84Q27694726-740D093F-5E63-475D-AA5B-4A7A17314459Q28072503-5F8420ED-1C32-4509-A879-733B135B0D30Q28386869-E8AA42A4-ED24-44B0-BEC3-FE1ED9F4B854Q28740296-60C9B433-AEDD-4AF0-AE45-22C3D46CF241Q30468251-38F17BAF-C33E-43EF-847A-EFB37DEE2B90Q30525336-4BB8098D-8C1B-45E7-A8CA-4D34624F07A2Q30579220-98E2CA9C-E572-4D99-8EED-BEED18D6962BQ33793574-23191749-2DAC-4CAD-879F-3059810F68F8Q35626522-81C7AC4B-3346-4515-8547-41A62C5FE5BFQ35650805-01EDE3B4-A05F-48DA-BFBD-1F8A519216C8Q35669733-D1698E88-EFFE-4777-995C-3EC1AB042F87Q36043823-F3D73BB1-E65B-4A47-9C56-5D570B3C9A10Q36302985-A2BFD38D-7D48-425E-BA8E-CD84F14BB613Q36332001-2196955E-ED80-4306-A656-6835614FDB04Q36462069-E09E11E0-3768-442B-99F3-C985CBA2ACF1Q36855902-17D7C2CE-2B6C-4C74-B834-B06AF73916CEQ37327576-8697AF4C-986A-490D-B433-440040B215B2Q37448116-227DC604-C396-4AE8-8B69-98F9E17E2000Q37597900-25C07296-B6A7-4DC8-B414-DFE4436D9686Q37717475-204648CD-7902-401E-8694-FCC8EDAFDD80Q37980136-10E4BB5B-C924-407B-BCE7-F5D7CB06AEB6Q38043525-1393624B-1A17-447A-8D30-2939E1706829Q38135778-4A29D601-FB18-4FED-92DE-9CE608839C32Q38602808-A27B88E0-72F2-439B-91ED-0A9EF8FA0179Q38670009-38702493-7BBD-462D-9A2A-AF8BDDCA36AEQ39017820-F9AF8C61-DCF9-4859-8919-4D5A12BEAD3AQ39052318-DE383923-5176-410A-A70C-3217187ECFEDQ39728613-FB72087B-4027-4059-A4EB-C73B13C08418Q41141822-BE3361C6-DCA9-47C4-9E9C-81B7F4F09540Q41879186-8076CF48-655A-4332-B563-7FD04DFAAE6FQ42424833-3F15765B-CAA4-4C0A-884E-3BE44F5F7092Q42877755-B280F30F-3D97-4C9C-A415-0F877AB859BDQ42932374-AA5EC7B4-8C30-4BF2-A1D7-932240C670A5Q44385177-158819C4-1C93-45FA-A668-C4ABE4229477Q44759466-CA53FD36-70D0-4D77-BEC3-1D3A87471C77Q48172143-E79906EA-6677-4514-98D5-3C32A9BF94B8Q49215171-8574D2B5-6D89-44F3-849A-E34237247856
P2860
Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased exposure of phosphat ...... of tumor vascular endothelium
@ast
Increased exposure of phosphat ...... of tumor vascular endothelium
@en
Increased exposure of phosphat ...... of tumor vascular endothelium
@nl
type
label
Increased exposure of phosphat ...... of tumor vascular endothelium
@ast
Increased exposure of phosphat ...... of tumor vascular endothelium
@en
Increased exposure of phosphat ...... of tumor vascular endothelium
@nl
prefLabel
Increased exposure of phosphat ...... of tumor vascular endothelium
@ast
Increased exposure of phosphat ...... of tumor vascular endothelium
@en
Increased exposure of phosphat ...... of tumor vascular endothelium
@nl
P2860
P356
P1433
P1476
Increased exposure of phosphat ...... of tumor vascular endothelium
@en
P2093
Jason H Stafford
Philip E Thorpe
P2860
P304
P356
10.1593/NEO.101366
P577
2011-04-01T00:00:00Z